Loading...
NPI 1255608469 · Tampa, FL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Apex Labs, Inc is a clinical medical laboratory provider located in Tampa, Florida. This profile covers 5 Medicare and 47 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Apex Labs, Inc |
| Address | 6015 Benjamin Rd |
| City | Tampa |
| State | FL |
| ZIP | 33634 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | November 17, 2011 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $1.6M |
| Medicare | $427.3K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 650 | $200 | $125.8K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 410 | $240 | $99.5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 680 | $110 | $76K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 1,230 | $60 | $75.2K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 330 | $150 | $50.9K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 5 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
47 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 13,910 | $10 | $167K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 26,660 | $10 | $159.9K |
| 80325 | The lab analyst measures the amount of or detects the presence of three or four amphetamines, a central nervous system stimulant in the patient specimen. | 8,920 | $20 | $151.7K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 10,150 | $10 | $142K |
| 80339 | The lab analyst measures the amount of or detects the presence of one to three antiepileptics in a patient specimen. The antiepileptics the provider is testing for are not specified in other CPT®… | 6,880 | $10 | $89.4K |
| 80324 | The lab analyst measures the amount of or detects the presence of one or two amphetamines, a central nervous system stimulant in a patient specimen. | 5,200 | $10 | $52K |
| 80354 | The lab analyst measures the amount of or detects the presence of fentanyl in the patient specimen. | 12,230 | $1 | $48.9K |
| 80346 | The lab analyst measures the amount of or detects the presence of one to twelve benzodiazepines, which are tranquilizers, in a patient specimen. | 11,440 | $1 | $45.7K |
| 80356 | The lab analyst measures the amount of or detects the presence of heroin metabolite in the patient specimen. | 13,340 | $1 | $40K |
| 80365 | The lab analyst measures the amount of or detects the presence of oxycodone, a synthetic opioid pain medication, in a patient specimen. | 19,450 | $1 | $38.9K |
Showing 1–10 of 47
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
47 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 6 | 40 | 320 | $100 | $620K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 5 | 50 | 360 | $40 | $96.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 12 | 450 | 1,380 | $20 | $75.1K |
| 80325 | The lab analyst measures the amount of or detects the presence of three or four amphetamines, a central nervous system stimulant in the patient specimen. | 3 | 10 | 4,400 | $10 | $64.3K |
| 80339 | The lab analyst measures the amount of or detects the presence of one to three antiepileptics in a patient specimen. The antiepileptics the provider is testing for are not specified in other CPT®… | 2 | 10 | 4,390 | $10 | $62K |
| 80351 | The lab analyst measures the amount of or detects the presence of four to six synthetic cannabinoids present in the patient specimen. | 2 | 10 | 3,380 | $10 | $53.6K |
| 80324 | The lab analyst measures the amount of or detects the presence of one or two amphetamines, a central nervous system stimulant in a patient specimen. | 6 | 30 | 420 | $20 | $45K |
| 80338 | The lab analyst measures the amount of or detects the presence of antidepressants, which are psychiatric medications, in a patient specimen. The antidepressants the provider is testing for are not… | 4 | 10 | 4,980 | $1 | $34K |
| 80333 | The lab analyst measures the amount of or detects the presence of three to five serotonergic antidepressants, which are psychiatric medications, in a patient specimen. | 3 | 10 | 1,410 | $10 | $33.5K |
| 80323 | The lab analyst identifies and evaluates the level of alkaloid drugs in a patient specimen that are not specified elsewhere in CPT® by a different code from the class of alkaloids. | 4 | 20 | 850 | $10 | $30.2K |
Showing 1–10 of 47
Other providers in the same ZIP code as Apex Labs, Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Option Care Enterprises, Inc. | FL | Home Infusion Therapy Pharmacy | $0 | $29.3M |
| Families First Of Florida LLC | FL | Community/Behavioral Health Agency | $0 | $25.4M |
| Carecentrix, Inc. | FL | Case Management Agency | $0 | $13.7M |
| Bioscrip Infusion Services, LLC | FL | Home Infusion Therapy Pharmacy | $0 | $12.5M |
| Ruffolo Hooper & Associates Md PA | FL | Anatomic Pathology & Clinical Pathology Physician | $0 | $10.1M |
| Eye Doctors Optical Outlets PA | FL | Optometrist | $0 | $9.2M |
| Physicians Toxicology Laboratory, LLC | FL | Clinical Medical Laboratory | $1.6M | $6.1M |
| Delivrxd LLC | FL | Community/Retail Pharmacy | $4.3M | $1.9K |
| Infiniti Labs, Inc | FL | Clinical Medical Laboratory | $798.4K | $2.5M |
| Gh Labb LLC | FL | Clinical Medical Laboratory | $1.2M | $198.1K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.